The metastasis‐associated molecule C4.4A promotes tissue invasion and anchorage independence by associating with the alpha6beta4 integrin
Authors:
Open Access
- 15 May 2013
- journal article
- Published by Wiley in Molecular Oncology
- Vol. 7 (5) , 917-928
Abstract
C4.4A is a metastasis‐associated molecule that functions appear to rely on associated alph6beta4 integrin. To corroborate the impact of the C4.4A‐alpha6beta4 integrin association on metastasis formation, C4.4A was knocked‐down in a highly metastatic rat pancreatic adenocarcinoma (ASML, ASML‐C4.4Akd).Metastasis formation by ASML‐C4.4Akd cells after intrafootpad application was strongly retarded in draining nodes and lung colonization was rare. Furthermore, cisplatin treatment significantly prolonged the survival time only of ASML‐C4.4Akd‐bearing rats. ASML‐C4.4Akd cells display reduced migratory activity and impaired matrix protein degradation due to inefficient MMP14 activation; loss of drug‐resistance is due to mitigated PI3K/Akt pathway activation. These losses of function rely on the laminin receptor C4.4A recruiting activated alpha6beta4 integrin into rafts, where C4.4A cooperates with alpha6beta4 and via alpha6beta4 with MMP14. Within this raft‐located complex, MMP14 provokes focalized matrix degradation and mostly alpha6beta4 integrin promotes BAD phosphorylation and upregulated Bcl2 and BclXl expression.Thus, metastasis‐promoting activities of C4.4A are not genuine characteristics of C4.4A. Instead, the raft‐located laminin receptor C4.4A recruits alpha6beta4 integrin and supports via the alpha6beta4 integrin MMP14 activation. Thereby C4.4A acts as a linker to facilitate several steps in the metastatic cascade. Taking the restricted C4.4A expression in non‐transformed tissue, this knowledge should pave the way toward the use of C4.4A as a therapeutic target.Keywords
Funding Information
- Deutsche Krebshilfe (10-1821-Z3)
This publication has 57 references indexed in Scilit:
- Deciphering the rules of programmed cell death to improve therapy of cancer and other diseasesThe EMBO Journal, 2011
- CD44v6 Coordinates Tumor Matrix-triggered Motility and Apoptosis ResistanceJournal of Biological Chemistry, 2011
- EGF-induced MAPK Signaling Inhibits Hemidesmosome Formation through Phosphorylation of the Integrin β4Journal of Biological Chemistry, 2010
- CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinasesExpert Reviews in Molecular Medicine, 2009
- C4.4A as a candidate marker in the diagnosis of colorectal cancerBritish Journal of Cancer, 2007
- Intrinsic Signaling Functions of the β4 Integrin Intracellular DomainJournal of Biological Chemistry, 2007
- Targeting integrin β4 for cancer and anti-angiogenic therapyTrends in Pharmacological Sciences, 2007
- β4 Integrin and Epidermal Growth Factor Coordinately Regulate Electric Field-mediated Directional Migration via Rac1Molecular Biology of the Cell, 2006
- Integrin β4 Regulates Migratory Behavior of Keratinocytes by Determining Laminin-332 OrganizationJournal of Biological Chemistry, 2006
- Multiple Functions of the Integrin α6β4 in Epidermal Homeostasis and TumorigenesisMolecular and Cellular Biology, 2006